Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
690.00
Ask:
710.00
Spread: 20.00 (2.899%)
Market Cap: £246.67m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares
22nd Aug 20233:19 pmRNSTransaction in Own Shares
21st Aug 20234:12 pmRNSTransaction in Own Shares
18th Aug 20235:06 pmRNSTransaction in Own Shares
17th Aug 20235:25 pmRNSTransaction in Own Shares
16th Aug 202311:41 amRNSTransaction in Own Shares
15th Aug 202311:54 amRNSTransaction in Own Shares
11th Aug 202312:21 pmRNSTransaction in Own Shares
10th Aug 20239:28 amRNSTransaction in Own Shares
9th Aug 20233:24 pmRNSTransaction in Own Shares
9th Aug 20231:44 pmRNSInvestee Company Update - LEBC
8th Aug 20235:23 pmRNSHolding(s) in Company
7th Aug 20234:25 pmRNSShare Buy-Back Policy
4th Aug 20234:00 pmRNSPDMR and Director Dealings
3rd Aug 20238:58 amRNSTransaction in Own Shares
1st Aug 20235:00 pmRNSTransaction in Own Shares
31st Jul 20232:17 pmRNSTransaction in Own Shares
26th Jul 20234:07 pmRNSResult of AGM
25th Jul 20234:22 pmRNSTransaction in Own Shares
25th Jul 20233:25 pmRNSTransaction in Own Shares
21st Jul 20231:17 pmRNSTransaction in Own Shares
19th Jul 20233:44 pmRNSTransaction in Own Shares
18th Jul 202311:36 amRNSTransaction in Own Shares
11th Jul 20234:02 pmRNSTransaction in Own Shares
10th Jul 20232:41 pmRNSTransaction in Own Shares
30th Jun 202312:05 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSNotice of AGM
27th Jun 20233:06 pmRNSTransaction in Own Shares
26th Jun 202311:43 amRNSTransaction in Own Shares
22nd Jun 202310:59 amRNSTransaction in Own Shares
21st Jun 20231:10 pmRNSNew Investment – Pantheon Specialty Limited
21st Jun 202311:53 amRNSTransaction in Own Shares
19th Jun 20231:15 pmRNSTransaction in Own Shares
13th Jun 202312:08 pmRNSDividend payment date correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.